Stay updated on Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Sign up to get notified when there's something new on the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.

Latest updates to the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study page adds a new site in New Delhi (Sir Gangaram Hospital) and updates overall locations, while introducing new/modified outcomes such as T1Gd+ lesion counts, an SDMT worsening definition, and NfL biomarker measurements with extended timeframes; the Pune site (Sahyadri Hospital) has been removed.SummaryDifference0.9%

- Check20 days agoChange DetectedRevision: v3.6.6 replaces the previous Revision: v3.6.5 on the page. This reflects a newer build of the site’s software used for the study detail page.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a software version update for the site.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision label updated from v3.6.3 to v3.6.4. This indicates a minor update to the study record on the ClinicalTrials.gov page.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2, signaling a recent site update.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded Freire Pesquisa Clinica in Belo Horizonte, Minas Gerais, Brazil (address 30150-320); the page now lists 106 locations. Removed sites such as Sir Gangaram Hospital (New Delhi) and KI Health Partners (Stamford), updated the location count and revision to v3.6.2.SummaryDifference0.4%

Stay in the know with updates to Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.